• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of internal pediatric review committee meetings attended per month

Dictionary: The internal pediatric committee meeting is intended to assure high quality and inform pediatric development plan that will impact labeling and drug approvals.


This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.

Fiscal Year - 2010

Skip graphic and jump to text data

TimeTargetNumber
Oct 2009N/A5
Nov 2009N/A3
Dec 2009N/A4
Jan 2010N/A4
Feb 2010N/A9
Mar 2010N/A5
Apr 2010N/A11
May 2010N/A11
Jun 2010N/A13
Jul 2010N/A12
Aug 2010N/A10
Sep 2010N/A12

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.